Today's market brief highlights key filings and announcements from various companies, including acquisitions, sales, and new listings. The announcements are expected to have a positive impact on the companies' financials and growth prospects.
Ipsen's acquisition of Memo Therapeutics AG for up to €900m expands its rare disease portfolio with a first-in-class BK polyomavirus antibody, a significant addition given the promising Phase II trial results.
VIEW FILING →Brockhaus Technologies AG has completed the sale of its 52% stake in the Bikeleasing Group for a provisional purchase price of approximately €240 million, in line with previous estimates.
VIEW FILING →Relief Therapeutics' partner MindMaze Therapeutics has enrolled first patients in the SwissNeuroRehab study, a key step in advancing at-home neurorehabilitation reimbursement in Europe, which is a positive development for the company's growth prospects.
VIEW FILING →IDEX Biometrics ASA has appointed Ingvill Tømt as its new Chief Financial Officer, bringing extensive experience from senior finance roles at Telenor and Coop, which could support the company's commercial scale-up phase.
VIEW FILING →BayWa AG has reached an understanding to adjust its restructuring agreement, extending financial liabilities and providing interest relief, which could positively impact the company's financial stability.
VIEW FILING →Nasdaq Stockholm will list 20 mini futures warrants issued by J.P. Morgan SE, effective July 1, 2026, which may increase trading activity and liquidity for these securities.
VIEW FILING →J.P. Morgan SE is issuing 18 new mini futures to be listed on Nasdaq First North Sweden, effective July 1, 2026, providing additional trading opportunities for investors.
VIEW FILING →J.P. Morgan SE is listing 5 new mini futures warrants on Nasdaq First North Sweden, effective July 1, 2026, which may increase trading activity and liquidity for these securities.
VIEW FILING →J.P. Morgan SE is issuing 20 mini futures to be listed on Nasdaq First North Sweden, effective July 1, 2026, expanding trading opportunities for investors.
VIEW FILING →Bossard Holding AG will announce its semi-annual report for 2026 on July 21, 2026, with an audio webcast presentation at 3:00 pm CEST, no profit warning or significant update is provided in this announcement.
VIEW FILING →The filings and moves that matter, in your inbox every market day.
Subscribe free →